Sanjivani Paranteral Limited has initiated a postal ballot to seek shareholder approval for the preferential allotment of up to 5,00,000 fully convertible warrants to its promoter, Ashwani Khemka, aggregating ₹7,36,95,000. The Board of Directors sanctioned the deal on July 23, 2026, at an issue price of ₹147.39 per warrant. This capital raise aims to strengthen the company’s financial position through promoter backing, with the warrants convertible into equity shares within 18 months. The move also seeks approval for material related-party transactions up to ₹10 crore with subsidiary SPL Infusion Private Limited for FY26-27.

The remote e-voting period commenced on July 24, 2026, and concludes on August 22, 2026. Shareholders holding shares as on the cut-off date of July 17, 2026, are eligible to vote. The results will be announced by August 24, 2026. The issuance is structured as a related-party deal requiring a special resolution under Section 42 of the Companies Act, 2013, and Regulation 160 of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. The pricing was determined in accordance with Chapter V of the SEBI ICDR Regulations, based on market conditions as of the 'Relevant Date,' July 23, 2026.

Deal Structure and Pricing

The warrants will convert into fully paid-up equity shares with a face value of ₹10 each, at the option of the warrant holder, in one or more tranches. If any warrants remain unconverted after 18 months from the date of allotment, they will lapse, and the subscription amount paid by the holder will be forfeited to the company. The proposed allotment details are as follows:

Impact on Shareholding Pattern

Upon conversion, the promoter’s shareholding in Sanjivani Paranteral Limited is expected to increase. Currently, Ashwani Khemka holds 36,70,117 equity shares, representing a 29.88% stake. Post-conversion, his holding is projected to rise to 41,70,117 shares, increasing his stake to 32.62%. This consolidation reflects the promoter’s confidence in the company’s future prospects. The post-issue shareholding structure on a fully diluted basis is detailed below:

Related-Party Transactions

The Board also approved material related-party transactions between the company and its subsidiary, SPL Infusion Private Limited, pursuant to Regulation 23 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Shareholders are seeking an ordinary resolution to approve transactions including loans, guarantees, and purchase/sale of goods/services, not exceeding ₹10 crore during FY26-27. These transactions are intended to support the working capital requirements and business expansion of the subsidiary. The Audit Committee has reviewed the proposal, and the Board recommends it as being in the ordinary course of business and at arm's length.

Regulatory Approvals and Next Steps

The disclosure was submitted to BSE Limited under Regulation 30 of the SEBI Listing Regulations, signed by Company Secretary Ravikumar Venkatramalu Bogham on July 23, 2026. The company has engaged MUFG Intime India Private Limited to provide the remote e-voting facility. A practicing Company Secretary's certificate from HD & Associates confirms compliance with SEBI ICDR Regulations. The proceeds from the warrant issue, if converted, will be utilized for future expansion and growth by March 31, 2028, with interim funds deposited in scheduled commercial banks.

Ashwani Khemka, Managing Director of Sanjivani Paranteral, has increased his shareholding in the company by acquiring 16,875 equity shares through an open market transaction. The acquisition took place on June 24, 2026, as disclosed to the stock exchanges. Following this purchase, Khemka's total holding in the company has risen to 29.88% of the total paid-up share capital.

The disclosure was submitted to BSE Limited on June 25, 2026, in accordance with Regulation 29(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Khemka is classified as a promoter of the target company. The transaction details confirm that the mode of acquisition was the open market, and no other changes were reported in encumbrances or convertible securities.

Shareholding Details

The filing outlines the specific changes in Khemka's shareholding pattern. Prior to the acquisition, he held 36,53,242 shares, representing a 29.74% stake. The recent purchase of 16,875 shares, accounting for 0.14% of the capital, has adjusted his total position upward.

The following table summarizes the shareholding details before and after the transaction:

Transaction Overview

The total equity share capital and total voting capital of Sanjivani Paranteral before and after the acquisition remain unchanged at Rs. 12,28,43,000, comprising 1,22,84,300 shares of Rs. 10 each. The total diluted share/voting capital also remains at this figure. The disclosure confirms that the acquisition pertains solely to equity shares carrying voting rights, with no associated warrants or convertible instruments involved in this specific transaction.